Rheumatoid Arthritis Posts - Page 10 of 35 on Medivizor
Navigation Menu

Rheumatoid Arthritis Posts on Medivizor

Switching from adalimumab to baricitinib – what are the benefits for patients with rheumatoid arthritis?

Posted by on Jun 16, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if switching from adalimumab (Humira) to baricitinib (Olumiant) improves rheumatoid arthritis (RA) symptoms. They found that baricitinib (BAR) improved clinical outcomes in these patients. Some background Rheumatoid arthritis (RA) is a chronic condition. It is caused by inflammation that leads to painful...

Read More

Muscle function in rheumatoid arthritis – does resistance training improve functionality in women?

Muscle function in rheumatoid arthritis – does resistance training improve functionality in women?

Posted by on May 31, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated low load resistance training (LRT) to improve muscle function in women with rheumatoid arthritis (RA). They found that LRT improved muscle strength and function.  Some background Rheumatoid arthritis (RA) is a long-term condition. It is caused by painful inflammation in the joints. It can also lead to...

Read More

Namilumab – a safe and effective treatment for poor-responder patients with rheumatoid arthritis?

Namilumab – a safe and effective treatment for poor-responder patients with rheumatoid arthritis?

Posted by on May 30, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if namilumab is an effective treatment for patients with rheumatoid arthritis (RA) with a poor response to other therapies. They found that namilumab improved RA symptoms and was well tolerated. Some background Rheumatoid arthritis (RA) is a condition caused by inflammation. This leads to painful...

Read More

Treatment of eye disease in patients with juvenile idiopathic arthritis – a guideline.

Treatment of eye disease in patients with juvenile idiopathic arthritis – a guideline.

Posted by on May 21, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study reviewed the treatment of uveitis (a form of eye wall inflammation) in patients with juvenile idiopathic arthritis (JIA).  Some background Juvenile idiopathic arthritis (JIA) is a condition caused by inflammation. It affects children and leads to painful swelling in the joints. Children with JIA may also develop uveitis....

Read More

Does denosumab reduce joint damage in patients with rheumatoid arthritis?

Posted by on May 21, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the effectiveness of denosumab (Prolia) in rheumatoid arthritis (RA). They found that this treatment reduces joint damage and improves bone mineral density in these patients. Some background Rheumatoid arthritis (RA) is a long-term condition. Inflammation leads to painful swelling in the joints and joint...

Read More

Low white blood cells and tocilizumab: is there an increased infection risk in juvenile arthritis?

Posted by on Apr 8, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if neutropenia (NP; a low number of white blood cells that fight off infections) increases the risk of infection in patients with juvenile idiopathic arthritis (JIA) taking tocilizumab (Actemra). They found that NP during tocilizumab treatment did not increase the risk of infections in these...

Read More

Sarilumab in rheumatoid arthritis – an update on safety and effectiveness

Sarilumab in rheumatoid arthritis – an update on safety and effectiveness

Posted by on Apr 8, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the safety and effectiveness of sarilumab (Kevzara) added to methotrexate in rheumatoid arthritis (RA). They found that sarilumab was clinically effective and well-tolerated.  Some background Rheumatoid arthritis (RA) is a long-term condition. It is caused by an excess of inflammation in the joints....

Read More